---
title: MDPV
description: 
published: true
date: 2026-01-30T09:34:43.699Z
tags: 
editor: markdown
dateCreated: 2026-01-30T05:55:58.444Z
---

[â—€è¿”å›](./home.md)

# MDPV

<mark> å¥½çš„å–µ</mark>

**MDPV å¯èƒ½å¯¼è‡´ [ç²¾ç¥ç—…](../è¯æ•ˆ/ç²¾ç¥ç—….md)ã€[ç‹‚èº](../è¯æ•ˆ/ç‹‚èº.md) å’Œæˆç˜¾çš„å‡ ç‡æ¯”å…¶ä»–å…´å¥‹å‰‚éƒ½è¦é«˜å‡ºå¾ˆå¤šå‘¢ã€‚**

å› ä¸ºå®ƒæŒç»­æ—¶é—´ç‰¹åˆ«é•¿ã€æ•ˆåŠ›æå¼ºï¼Œè€Œä¸”å¾ˆå®¹æ˜“è®©äººåœä¸ä¸‹æ¥ï¼Œæˆ‘ä»¬å¼ºçƒˆä¸å»ºè®®åœ¨é«˜å‰‚é‡ä¸‹æ»¥ç”¨è¿™ç§ç‰©è´¨ï¼Œä¹Ÿä¸è¦è¿ç»­å¤šå¤©ä½¿ç”¨ï¼Œæˆ–è€…å’Œå…¶ä»–å·²çŸ¥ä¼šå¢åŠ ç²¾ç¥ç—…é£é™©çš„è¯ç‰©ä¸€èµ·æ··ç”¨å“¦ã€‚MDPV æ˜¯å‡ ç§ä½œä¸ºâ€œ[æµ´ç›](https://en.wikipedia.org/wiki/Bath_salts_(drug))â€åœ¨ç¾å›½å’Œæ¬§æ´²å‡ºå”®çš„[ç­–åˆ’è¯](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/ç­–åˆ’è¯.md)ä¹‹ä¸€ï¼›åœ¨ 2009 å¹´ 9 æœˆåˆ° 2013 å¹´ 8 æœˆè¿™å››å¹´é—´ï¼Œæ¬§ç›Ÿ (EU) æŠ¥å‘Šäº†ä»¤äººæ‹…å¿§çš„å¤§é‡ä¸ MDPV ç›¸å…³çš„æ­»äº¡æ¡ˆä¾‹ï¼Œå±…ç„¶è¾¾åˆ°äº† 99 èµ·å‘¢ã€‚[\[1\]](#cite_note-EMCDDA-1)

è¯·æŸ¥çœ‹ [è¿™ä¸€éƒ¨åˆ†](#Toxicity_and_harm_potential) äº†è§£æ›´å¤šç»†èŠ‚å–µã€‚

| *[æ€»ç»“è¡¨: MDPV](../æ–‡æ¡£/è¯ç‰©/MDPV/Summary.md)* |
| --- |

| MDPV | |
| --- | --- |
| [![MDPV.svg](../æ–‡ä»¶/MDPV.svg)](../æ–‡ä»¶/MDPV.svg) | |
| åŒ–å­¦å‘½å | |
| å¸¸ç”¨å | *MDPV, Bath Salts (æµ´ç›), NRG\-1* |
| å–ä»£åç§° | *3,4\-äºšç”²åŒæ°§åŸºå¡å’¯æˆŠé…® (3,4\-Methylenedioxypyrovalerone)* |
| ç³»ç»Ÿå | *1\-(1,3\-Benzodioxol\-5\-yl)\-2\-(pyrrolidin\-1\-yl)pentan\-1\-one* |
| ç±»åˆ«æˆå‘˜ | |
| ç²¾ç¥æ´»æ€§åˆ†ç±» | *[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md) / [å…±æƒ…å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…±æƒ…å‰‚.md)* |
| åŒ–å­¦åˆ†ç±» | *[å¡è¥¿é…®ç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¡è¥¿é…®ç±»ç‰©è´¨.md) / [äºšç”²åŒæ°§åŸºè‹¯ç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/äºšç”²åŒæ°§åŸºè‹¯ç±»ç‰©è´¨.md) / [å¡å’¯æˆŠé…®](../è¯ç‰©/å¡å’¯æˆŠé…®.md)* |
| [ç»™è¯é€”å¾„](../æ–‡æ¡£/ç»™è¯é€”å¾„.md) | |
| - **è­¦å‘Š:** ç”±äºä¸ªä½“ä½“é‡ã€è€å—æ€§ã€ä»£è°¢å’Œä¸ªäººæ•æ„Ÿåº¦çš„å·®å¼‚ï¼Œè¯·åŠ¡å¿…ä»è¾ƒä½å‰‚é‡å¼€å§‹å“¦ã€‚[å‚è§è´Ÿè´£ä»»çš„ç”¨è¯éƒ¨åˆ†](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)ã€‚ <br>   <br>    | â‡£ [å£æœ](../æ–‡æ¡£/ç»™è¯é€”å¾„.md) |
| [å‰‚é‡](../æ–‡æ¡£/ç»™è¯å‰‚é‡.md) | |
| [é˜ˆå€¼](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md) | 2 mg |
| [è½»å¾®](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md) | 4 \- 8 mg |
| [ä¸­ç­‰](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md) | 8 \- 14 mg |
| [å¼ºçƒˆ](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md) | 14 \- 25 mg |
| [ä¸¥é‡](../æ–‡æ¡£/è¯ç‰©å‰‚é‡åˆ†ç±».md) | 25 mg \+ |
| [æ—¶é•¿](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md) | |
| [æ€»æ—¶é•¿](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md) | 2 \- 7 å°æ—¶ |
| [è¯æ•ˆå‘ä½œ](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md) | 15 \- 30 åˆ†é’Ÿ |
| [è¯æ•ˆè¾¾å³°](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md) | 1 \- 4 å°æ—¶ |
| [è¯æ•ˆè¤ªå»](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md) | 0\.5 \- 2 å°æ—¶ |
| [è¯æ•ˆæ®‹ä½™](../æ–‡æ¡£/è¯æ•ˆæ—¶é•¿.md) | 2 \- 48 å°æ—¶ |
| <br>   <br>   <br>   <br>   <br>   <br>   <br>   <br>    - **[å…è´£å£°æ˜](../å…³äºæœ¬ç«™/å…è´£å£°æ˜.md):** æœ¬ç«™çš„ [å‰‚é‡](../æ–‡æ¡£/ç»™è¯å‰‚é‡.md) ä¿¡æ¯æ˜¯ä»ç”¨æˆ·å’Œ [èµ„æº](../å…³äºæœ¬ç«™/ç½‘ç»œèµ„æº.md) ä¸­æ”¶é›†çš„ï¼Œä»…ç”¨äºæ•™è‚²ç›®çš„å–µã€‚è¿™ä¸æ˜¯æ¨èï¼Œåº”è¯¥ä¸å…¶ä»–æ¥æºæ ¸å®å‡†ç¡®æ€§å“¦ã€‚ | |
| [ç›¸äº’ä½œç”¨](#Dangerous_interactions) | |
| é…’ç²¾ | âš ï¸ è°¨æ…è”ç”¨ |
| MXE | â›” ä¸¥ç¦è”ç”¨ |
| è§£ç¦»å‰‚ | âš ï¸ è°¨æ…è”ç”¨ |
| å³ç¾æ²™èŠ¬ | ğŸ’” è”ç”¨å±é™© |
| MDMA | ğŸ’” è”ç”¨å±é™© |
| å…´å¥‹å‰‚ | ğŸ’” è”ç”¨å±é™© |
| 25x-NBOMe | â›” ä¸¥ç¦è”ç”¨ |
| 25x-NBOH | â›” ä¸¥ç¦è”ç”¨ |
| æ›²é©¬å¤š | ğŸ’” è”ç”¨å±é™© |
| å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚ | â›” ä¸¥ç¦è”ç”¨ |

**3,4-äºšç”²åŒæ°§åŸºå¡å’¯æˆŠé…®** (ä¹Ÿç§°ä¸º **MDPV**ï¼Œä»¥åŠ **Monkey Dust (çŒ´å°˜)**[\[2\]](#cite_note-2)) æ˜¯ä¸€ç§ [å¡è¥¿é…®ç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¡è¥¿é…®ç±»ç‰©è´¨.md) å’Œ [å¡å’¯æˆŠé…®](../è¯ç‰©/å¡å’¯æˆŠé…®.md) ç±»åˆ«çš„æ–°å‹ã€é²œä¸ºäººçŸ¥çš„ [å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md) ç‰©è´¨ã€‚å®ƒè¢«è®¤ä¸ºæ˜¯æ•ˆåŠ›æœ€å¼ºã€æœ€çŒ›çƒˆçš„å…´å¥‹å‰‚ä¹‹ä¸€ã€‚æ®ä¿¡ MDPV ä¸»è¦ä½œä¸ºä¸€ç§ [å»ç”²è‚¾ä¸Šè…ºç´ ](../æ–‡æ¡£/å»ç”²è‚¾ä¸Šè…ºç´ .md)-[å¤šå·´èƒº](../æ–‡æ¡£/å¤šå·´èƒº.md) [å†æ‘„å–æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨å†æ‘„å–æŠ‘åˆ¶å‰‚.md) (NDRI) å‘æŒ¥ä½œç”¨ã€‚

MDPV æœ€æ—©æ˜¯åœ¨ 1960 å¹´ä»£ç”±å‹ƒæ—æ ¼æ®·æ ¼ç¿°çš„ä¸€ä¸ªå›¢é˜Ÿå¼€å‘çš„ã€‚[\[3\]](#cite_note-KoppePatent-3) å½“æ—¶å£°ç§°å®ƒæœ‰æ½œåŠ›æˆä¸ºå¤–æ¶ˆæ—‹è‹¯ä¸™èƒºçš„æ›¿ä»£å“ï¼Œå°½ç®¡ä¸è‹¯ä¸™èƒºç›¸æ¯”ç¡®å®æ˜¾ç¤ºå‡ºä¸€äº›ç†æƒ³çš„å“è´¨ï¼Œä¾‹å¦‚æ¯’æ€§é™ä½ï¼Œä½†æœ€ç»ˆè¿˜æ˜¯æ²¡æœ‰è¢«å¼€å‘æˆè¯ç‰©ã€‚[\[4\]](#cite_note-4)

ç›´åˆ° 2004 å¹´å·¦å³ï¼ŒMDPV ä¹‹å‰ä¸€ç›´æ˜¯ä¸€ç§é»˜é»˜æ— é—»çš„å…´å¥‹å‰‚ï¼Œæ®æŠ¥é“é‚£æ˜¯å®ƒç¬¬ä¸€æ¬¡ä½œä¸º [ç­–åˆ’è¯](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/ç­–åˆ’è¯.md) å‘å…¬ä¼—æä¾›ã€‚è´´æœ‰â€œæµ´ç›â€æ ‡ç­¾ä¸”å«æœ‰ MDPV çš„äº§å“ä»¥å‰æ›¾åœ¨ç¾å›½çš„åŠ æ²¹ç«™å’Œä¾¿åˆ©åº—ä½œä¸ºå¨±ä¹æ€§è¯ç‰©å‡ºå”®ï¼Œå°±åƒ [Spice å’Œ K2](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/åˆæˆå¤§éº»ç´ ç±»ç‰©è´¨.md) ä½œä¸ºé¦™ä¸€æ ·é”€å”®çš„è¥é”€ç­–ç•¥ç±»ä¼¼ã€‚\[*[æ¥æºè¯·æ±‚](../å…³äºæœ¬ç«™/æ¥æºè¯·æ±‚.md)*\]

ä¸»è§‚æ•ˆåº”åŒ…æ‹¬ [åˆºæ¿€](../è¯æ•ˆ/åˆºæ¿€.md)ã€[å»æŠ‘åˆ¶](../è¯æ•ˆ/å»æŠ‘åˆ¶.md)ã€[æ€§æ¬²å¢å¼º](../è¯æ•ˆ/æ€§æ¬²å¢å¼º.md)ã€[é£Ÿæ¬²æŠ‘åˆ¶](../è¯æ•ˆ/é£Ÿæ¬²æŠ‘åˆ¶.md) å’Œå¼ºçƒˆçš„ [æ¬£å¿«æ„Ÿ](../è¯æ•ˆ/è®¤çŸ¥æ•ˆåº”.md#cognitive-euphoria)ã€‚

å·²ç»æœ‰å¤šèµ·å¿ƒç†å’Œèº«ä½“ä¼¤å®³äº‹ä»¶å½’å› äº MDPV çš„ä½¿ç”¨ï¼ŒåŒ…æ‹¬æ•°é‡å¤šå¾—ä¸æ­£å¸¸çš„æ­»äº¡äº‹ä»¶ã€‚ä¹ä¸ªæ¬§æ´²å›½å®¶æŠ¥å‘Šç§°ï¼Œåœ¨ 2009 å¹´ 9 æœˆè‡³ 2013 å¹´ 8 æœˆæœŸé—´ï¼Œå…±æœ‰ 107 èµ·éè‡´å‘½ä¸­æ¯’äº‹ä»¶å’Œ 99 èµ·ç»åˆ†æç¡®è®¤ä¸ MDPV ç›¸å…³çš„æ­»äº¡äº‹ä»¶ã€‚[\[1\]](#cite_note-EMCDDA-1)

å¦‚æœä½¿ç”¨è¿™ç§ç‰©è´¨ï¼Œéå¸¸å»ºè®®é‡‡å– [ä¼¤å®³å‡å°‘æªæ–½](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md) å–µã€‚

ç›®å½•
--------

* [1 åŒ–å­¦](#Chemistry)
* [2 è¯ç†å­¦](#Pharmacology)
* [3 ä¸»è§‚æ•ˆåº”](#Subjective_effects)
    + [3\.1 **èº¯ä½“æ•ˆåº”**](#Physical_effects)
    + [3\.2 **å¬è§‰æ•ˆåº”**](#Auditory_effects)
    + [3\.3 **è¯æ•ˆæ®‹ä½™**](#After_effects)
    + [3\.4 **è®¤çŸ¥æ•ˆåº”**](#Cognitive_effects)
    + [3\.5 ä½“éªŒæŠ¥å‘Š](#Experience_reports)
* [4 æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›](#Toxicity_and_harm_potential)
    + [4\.1 è‡´æ­»å‰‚é‡](#Lethal_dosage)
    + [4\.2 ä¾èµ–æ€§å’Œæ»¥ç”¨æ½œåŠ›](#Dependence_and_abuse_potential)
    + [4\.3 ç²¾ç¥ç—…](#Psychosis)
    + [4\.4 å±é™©çš„ç›¸äº’ä½œç”¨](#Dangerous_interactions)
* [5 æ³•å¾‹åœ°ä½](#Legal_status)
* [6 å¦è§](#See_also)
* [7 å¤–éƒ¨é“¾æ¥](#External_links)
    + [7\.1 è®¨è®º](#Discussion)
* [8 å‚è€ƒæ–‡çŒ®](#References)

åŒ–å­¦
---------

MDPVï¼Œå³ 3,4-äºšç”²åŒæ°§åŸºå¡å’¯æˆŠé…®ï¼Œæ˜¯ä¸€ç§åˆæˆçš„ [å¡è¥¿é…®](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¡è¥¿é…®ç±»ç‰©è´¨.md) å’Œ [å¡å’¯æˆŠé…®](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¡å’¯æˆŠé…®ç±»ç‰©è´¨.md) ç±»å…´å¥‹å‰‚ã€‚MDPV æ˜¯ 1960 å¹´ä»£å¼€å‘çš„åŒ–åˆç‰© [Î±-PVP](../è¯ç‰©/Î±-PVP.md) çš„ 3,4-äºšç”²åŒæ°§åŸºç¯å–ä»£ç±»ä¼¼ç‰©ï¼Œåè€…æ›¾ç”¨äºæ²»ç–—æ…¢æ€§ç–²åŠ³å’Œä½œä¸ºä¸€ç§åŒé£Ÿè¯ï¼Œä½†å¼•èµ·äº†æ»¥ç”¨å’Œä¾èµ–é—®é¢˜ã€‚[\[3\]](#cite_note-KoppePatent-3)

ç„¶è€Œï¼Œå°½ç®¡æœ‰ä¸€äº›å…±åŒçš„ç»“æ„ç‰¹å¾ï¼ŒMDPV çš„æ•ˆæœä¸å…¶ä»–çš„äºšç”²åŒæ°§åŸºè‹¯çƒ·åŸºèƒºè¡ç”Ÿç‰©ï¼ˆå¦‚ 3,4-äºšç”²åŒæ°§åŸºç”²åŸºè‹¯ä¸™èƒº ([MDMA](../è¯ç‰©/MDMA.md))ï¼‰å‡ ä¹æ²¡æœ‰ç›¸ä¼¼ä¹‹å¤„ï¼Œå®ƒä¸»è¦äº§ç”Ÿç»å…¸çš„å…´å¥‹å‰‚æ•ˆæœï¼Œåªæœ‰è½»å¾®çš„å…±æƒ…ç‰¹è´¨ã€‚[\[5\]](#cite_note-5)

MDPV åœ¨ç»“æ„ä¸Šä¸å¡è¥¿é…®ï¼ˆæ°ç‰¹è‰ä¸­å‘ç°çš„ä¸€ç§æ´»æ€§ç”Ÿç‰©ç¢±ï¼‰ã€3,4-äºšç”²åŒæ°§åŸºç”²åŸºè‹¯ä¸™èƒº (MDMA)ã€ç”²åŸºè‹¯ä¸™èƒºå’Œå…¶ä»–é™„è¡¨ I çš„è‹¯ä¹™èƒºç±»ç‰©è´¨æœ‰å…³ã€‚MDPV å’Œè¯¥ç±»åˆ«ä¸­çš„å…¶ä»–ä¸€äº›ç‰©è´¨ä¸€æ ·ï¼Œæ˜¯ä¸€ç§ä¸­æ¢ç¥ç»ç³»ç»Ÿ (CNS) å…´å¥‹å‰‚ã€‚æ®æŠ¥é“ï¼ŒMDPV ä¹Ÿå…·æœ‰è‡´å¹»æ•ˆæœã€‚[\[6\]](#cite_note-6)

è¯ç†å­¦
------------

æ®ä¿¡ MDPV ä¸»è¦ä½œä¸ºä¸€ç§å¼ºæ•ˆçš„ [å»ç”²è‚¾ä¸Šè…ºç´ ](../æ–‡æ¡£/å»ç”²è‚¾ä¸Šè…ºç´ .md)-[å¤šå·´èƒº](../æ–‡æ¡£/å¤šå·´èƒº.md) [å†æ‘„å–æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/ç¥ç»é€’è´¨å†æ‘„å–æŠ‘åˆ¶å‰‚.md) å‘æŒ¥ä½œç”¨ã€‚å»ç”²è‚¾ä¸Šè…ºç´ å’Œå¤šå·´èƒºçš„å†æ‘„å–å‡å°‘ï¼Œå¯¼è‡´è¿™ä¸¤ç§ [å„¿èŒ¶é…šèƒº](../æ–‡æ¡£/ç¥ç»é€’è´¨.md) [ç¥ç»é€’è´¨](../æ–‡æ¡£/ç¥ç»é€’è´¨.md) åœ¨ [çªè§¦é—´éš™](../æ–‡æ¡£/ç¥ç»é€’è´¨.md)ï¼ˆå³ [ç¥ç»å…ƒ](../æ–‡æ¡£/ç¥ç»é€’è´¨.md) ä¹‹é—´çš„é—´éš™ï¼‰ä¸­çš„æµ“åº¦å‡é«˜ã€‚

è¿™ç§æŠ‘åˆ¶çš„ç»“æœæ˜¯ï¼Œæ¥æ”¶ç¥ç»å…ƒä¸Šçš„å¤šå·´èƒºå’Œå»ç”²è‚¾ä¸Šè…ºç´ å—ä½“çš„å¤šå·´èƒºèƒ½å’Œå»ç”²è‚¾ä¸Šè…ºç´ èƒ½ä¿¡å·ä¼ å¯¼çš„æµ“åº¦å’Œäº§ç”Ÿçš„çªè§¦åæ•ˆåº”å¢å¼ºå¹¶å»¶é•¿äº†ã€‚[è¡€æ¸…ç´ ](../æ–‡æ¡£/è¡€æ¸…ç´ .md) ä¹Ÿèµ·ä½œç”¨ï¼Œè™½ç„¶ç¨‹åº¦è¦å°å¾—å¤šã€‚å¤§è„‘ä¸­ç¥ç»é€’è´¨æµ“åº¦çš„çªç„¶å¢åŠ è¢«è®¤ä¸ºæ˜¯ MDPV äº§ç”Ÿå¿«æ„Ÿçš„åŸå› å‘¢ã€‚

ç”±äºä¸»è¦å…·æœ‰å†æ‘„å–æŠ‘åˆ¶ç‰¹æ€§è€Œä¸æ˜¯é‡Šæ”¾ç‰¹æ€§ï¼ŒMDPV åœ¨ä½œç”¨æ–¹å¼ä¸Šå¯èƒ½æ›´åƒ [å¯å¡å› ](../è¯ç‰©/å¯å¡å› .md) æˆ– [å“Œç”²é…¯](../è¯ç‰©/å“Œç”²é…¯.md)ï¼Œè€Œä¸æ˜¯ [è‹¯ä¸™èƒº](../è¯ç‰©/è‹¯ä¸™èƒº.md)ã€‚[\[7\]](#cite_note-7) ç›¸æ¯”ä¹‹ä¸‹ï¼Œè‹¯ä¸™èƒºä¸»è¦ä½œä¸ºæ¿€åŠ¨å‰‚ï¼Œé€šè¿‡æ¿€æ´» TAAR1 å—ä½“é—´æ¥é‡Šæ”¾å¤šå·´èƒºå’Œå»ç”²è‚¾ä¸Šè…ºç´ ã€‚

ä¸»è§‚æ•ˆåº”
------------------

***å…è´£å£°æ˜ï¼š** ä¸‹é¢åˆ—å‡ºçš„æ•ˆåº”å¼•ç”¨äº† [***ä¸»è§‚æ•ˆåº”ç´¢å¼•***](../æ–‡æ¡£/ç§‘å­¦ä¿¡æ¯ç´¢å¼•é¡µ.md) (**SEI**)ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäºè½¶äº‹ç”¨æˆ·æŠ¥å‘Šå’Œ [FreeODwiki](../å…³äºæœ¬ç«™/å…³äºFreeODwiki.md) è´¡çŒ®è€…ä¸ªäººåˆ†æçš„å¼€æ”¾ç ”ç©¶æ–‡çŒ®ã€‚å› æ­¤ï¼Œåº”è¯¥å¸¦ç€å¥åº·çš„æ€€ç–‘æ€åº¦æ¥çœ‹å¾…å®ƒä»¬å“¦ã€‚*

*åŒæ ·å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œè¿™äº›æ•ˆåº”å¹¶ä¸ä¸€å®šä¼šä»¥å¯é¢„æµ‹æˆ–å¯é çš„æ–¹å¼å‘ç”Ÿï¼Œå°½ç®¡é«˜å‰‚é‡æ›´å®¹æ˜“å¼•å‘å…¨æ–¹ä½çš„æ•ˆåº”ã€‚* åŒæ ·ï¼Œ**ä¸è‰¯ååº”** éšç€å‰‚é‡çš„å¢åŠ å˜å¾—è¶Šæ¥è¶Šå¯èƒ½å‘ç”Ÿï¼Œå¹¶ä¸”å¯èƒ½åŒ…æ‹¬ **æˆç˜¾ã€ä¸¥é‡ä¼¤å®³æˆ–æ­»äº¡** â˜ ã€‚

### **èº¯ä½“æ•ˆåº”** ![Child.svg](../æ–‡ä»¶/Child.svg)

*     + **[åˆºæ¿€](../è¯æ•ˆ/åˆºæ¿€.md)**
    + **[è€åŠ›å¢å¼º](../è¯æ•ˆ/è€åŠ›å¢å¼º.md)**\[*[æ¥æºè¯·æ±‚](../å…³äºæœ¬ç«™/æ¥æºè¯·æ±‚.md)*\]
    + **[å¿ƒå¾‹å¼‚å¸¸](../è¯æ•ˆ/å¿ƒå¾‹å¼‚å¸¸.md)**\[*[æ¥æºè¯·æ±‚](../å…³äºæœ¬ç«™/æ¥æºè¯·æ±‚.md)*\]
    + **[å¿ƒç‡å¢å¿«](../è¯æ•ˆ/å¿ƒç‡å¢å¿«.md)**\[*[æ¥æºè¯·æ±‚](../å…³äºæœ¬ç«™/æ¥æºè¯·æ±‚.md)*\] \- è¾ƒé«˜å‰‚é‡çš„ MDPV ä¼šå¯¼è‡´å¿ƒç‡å’Œè¡€å‹æ˜¾ç€ä¸”é€šå¸¸å±é™©åœ°å‡é«˜ã€‚
    + **[è‚Œè‚‰æ”¶ç¼©](../è¯æ•ˆ/è‚Œè‚‰ç´§å¼ .md)**
    + **[è‚Œè‚‰ç—‰æŒ›](../è¯æ•ˆ/è‚Œè‚‰ç—‰æŒ›.md)**
    + **[é£Ÿæ¬²æŠ‘åˆ¶](../è¯æ•ˆ/é£Ÿæ¬²æŠ‘åˆ¶.md)**
    + **[å¤´ç—›](../è¯æ•ˆ/å¤´ç—›.md)**
    + **[å‘³è§‰å¹»è§‰](../è¯æ•ˆ/å¹»è§‰.md)**
    + **[è…¹æ³»](../è¯æ•ˆ/è…¹æ³».md)** \- ä¸€äº›ç”¨æˆ·æŠ¥å‘Šåœ¨ MDPV è¯æ•ˆä¸‹ç»å† [è…¹æ³»](../è¯æ•ˆ/è…¹æ³».md)ï¼Œä½†è¿™ä¼¼ä¹æ˜¯ä¸€ä¸ªç›¸å¯¹å°‘è§çš„æ•ˆåº”ã€‚
    + **[æ¶å¿ƒ](../è¯æ•ˆ/æ¶å¿ƒ.md)** \- ä¸€äº›ç”¨æˆ·æŠ¥å‘Šåœ¨ MDPV è¯æ•ˆä¸‹ç»å† [æ¶å¿ƒ](../è¯æ•ˆ/æ¶å¿ƒ.md)ï¼Œä½†è¿™ä¼¼ä¹æ˜¯ä¸€ä¸ªç›¸å¯¹å°‘è§çš„æ•ˆåº”ã€‚
    + **[ä¸å®è…¿ç»¼åˆå¾](../è¯æ•ˆ/ä¸å®è…¿.md)**

### **å¬è§‰æ•ˆåº”** ![Volume-up.svg](../æ–‡ä»¶/Volume-up.svg)

*     + **[å¬è§‰æ‰­æ›²](../è¯æ•ˆ/å¬è§‰æ•ˆåº”.md)**
    + **[å¹»å¬](../è¯æ•ˆ/å¹»å¬.md)**

### **è¯æ•ˆæ®‹ä½™** ![Aftereffects (3).svg](../æ–‡ä»¶/Aftereffects_(3).svg)

* å…´å¥‹å‰‚ä½“éªŒæ¶ˆé€€æœŸé—´å‘ç”Ÿçš„æ•ˆæœï¼Œä¸é«˜å³°æœŸå‘ç”Ÿçš„æ•ˆæœç›¸æ¯”ï¼Œé€šå¸¸æ„Ÿè§‰æ¶ˆæä¸”ä¸èˆ’æœã€‚è¿™é€šå¸¸è¢«ç§°ä¸ºâ€œä¸‹å¤´ (comedown)â€ï¼Œæ˜¯ç”±äºç¥ç»é€’è´¨è€—å°½é€ æˆçš„ã€‚å…¶æ•ˆåº”é€šå¸¸åŒ…æ‹¬ï¼š
    + **[ç„¦è™‘](../è¯æ•ˆ/ç„¦è™‘.md)**
    + **[è®¤çŸ¥ç–²åŠ³](../è¯æ•ˆ/è®¤çŸ¥ç–²åŠ³.md)**
    + **[æŠ‘éƒ](../è¯æ•ˆ/æŠ‘éƒ.md)**
    + **[æ˜“æ€’](../è¯æ•ˆ/æ˜“æ€’.md)**
    + **[åŠ¨æœºæŠ‘åˆ¶](../è¯æ•ˆ/åŠ¨æœºæŠ‘åˆ¶.md)**
    + **[æ€ç»´å‡é€Ÿ](../è¯æ•ˆ/æ€ç»´å‡é€Ÿ.md)**
    + **[æ¸…é†’](../è¯æ•ˆ/æ¸…é†’.md)**
å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œå¦‚æœæ˜¯å¼ºè¿«æ€§åœ°é‡å¤ç”¨è¯ï¼Œè®¸å¤šç”¨æˆ·è®¤ä¸º MDPV çš„è¯æ•ˆæ®‹ä½™ä¼šæ˜æ˜¾æ›´åŠ ä»¤äººä¸å¿«å“¦ã€‚[\[8\]](#cite_note-8)[\[9\]](#cite_note-9)

### **è®¤çŸ¥æ•ˆåº”** ![User.svg](../æ–‡ä»¶/User.svg)

* MDPV çš„ä¸€èˆ¬è®¤çŸ¥æ•ˆåº”å¯ä»¥æè¿°ä¸ºä¸å…¶ä»–å…¸å‹å…´å¥‹å‰‚ç›¸ä¼¼ã€‚åœ¨ä¸­ç­‰å‰‚é‡ä¸‹ï¼ŒMDPV çš„å¿«æ„Ÿè¢«æè¿°ä¸ºå…·æœ‰æ¬£å¿«æ„Ÿå’Œè½»å¾®çš„å…±æƒ…ä½œç”¨ï¼Œå¯¼è‡´åŠ¨æœºã€ç¤¾äº¤èƒ½åŠ›ã€æ€§æ¬²å’Œæ³¨æ„åŠ›å¢åŠ ã€‚ç„¶è€Œï¼Œè¾ƒé«˜å‰‚é‡çš„ MDPV ä¼šåŠ å‰§è®¸å¤šè´Ÿé¢å½±å“ï¼Œå¦‚ç„¦è™‘å’Œæ€ç»´æ··ä¹±ï¼›åœ¨æé«˜å‰‚é‡æˆ–æŒç»­ä½¿ç”¨ä¸‹ï¼Œå¦„æƒ³å’Œç²¾ç¥ç—…å˜å¾—å¾ˆå¯èƒ½å‘ç”Ÿã€‚[\[10\]](#cite_note-10)
    + **[ç„¦è™‘](../è¯æ•ˆ/ç„¦è™‘.md)**
    + **[è®¤çŸ¥æ¬£å¿«](../è¯æ•ˆ/è®¤çŸ¥æ¬£å¿«.md)**
    + **[å¼ºè¿«æ€§é‡å¤ç”¨è¯](../è¯æ•ˆ/å¼ºè¿«æ€§é‡å¤ç”¨è¯.md)** \- MDPV åœ¨è¿™ä¸€æ•ˆåº”ä¸Šæå¼ºï¼›ç ”ç©¶è¡¨æ˜ï¼Œå³ä½¿è´Ÿé¢å½±å“è¶…è¿‡äº†æ­£é¢å½±å“ï¼Œä¸€äº›ç”¨æˆ·æœ€ç»ˆè¿˜æ˜¯ä¼šé‡å¤ç”¨è¯ã€‚[\[11\]](#cite_note-11)[\[12\]](#cite_note-12)
    + **[å›°æƒ‘](../è¯æ•ˆ/å›°æƒ‘.md)** \- è¿™ç§æ•ˆåº”åœ¨è¾ƒé«˜å‰‚é‡å’Œé•¿æ—¶é—´ä¸ç¡è§‰åå¾ˆæ˜æ˜¾ã€‚
    + **[åˆ›é€ åŠ›å¢å¼º](../è¯æ•ˆ/åˆ›é€ åŠ›å¢å¼º.md)**
    + **[å¦„æƒ³](../è¯æ•ˆ/å¦„æƒ³.md)** \- è¿™ç§æ•ˆåº”ä¹Ÿå¯ä»¥åœ¨é«˜å‰‚é‡ä¸‹è¡¨ç°å‡ºæ¥ã€‚
    + **[è‡ªæˆ‘è†¨èƒ€](../è¯æ•ˆ/è‡ªæˆ‘è†¨èƒ€.md)**
    + **[å…±æƒ…ã€çˆ±å’Œç¤¾äº¤èƒ½åŠ›å¢å¼º](../è¯æ•ˆ/å…±æƒ…ã€çˆ±å’Œç¤¾äº¤èƒ½åŠ›å¢å¼º.md)** \- MDPV åœ¨è¿™æ–¹é¢çš„æ•ˆæœä¸ MDMA ç›¸ä¼¼ï¼Œä½†è¾ƒå¼±ã€‚
    + **[ä¸“æ³¨åŠ›å¢å¼º](../è¯æ•ˆ/ä¸“æ³¨åŠ›å¢å¼º.md)**
    + **[æ€§æ¬²å¢å¼º](../è¯æ•ˆ/æ€§æ¬²å¢å¼º.md)**
    + **[åŠ¨æœºå¢å¼º](../è¯æ•ˆ/åŠ¨æœºå¢å¼º.md)**
    + **[åæ‰§](../è¯æ•ˆ/åæ‰§.md)**
    + **[è€åŠ›å¢å¼º](../è¯æ•ˆ/è€åŠ›å¢å¼º.md)**
    + **[ç²¾ç¥ç—…](../è¯æ•ˆ/ç²¾ç¥ç—….md)** \- æ®äº†è§£ï¼Œé«˜å‰‚é‡çš„ MDPV æ¯”å¤§å¤šæ•°å…¶ä»–å…´å¥‹å‰‚æ›´é¢‘ç¹åœ°è¯±å‘ç²¾ç¥ç—…çŠ¶æ€ã€‚\[*[æ¥æºè¯·æ±‚](../å…³äºæœ¬ç«™/æ¥æºè¯·æ±‚.md)*\]
    + **[æ—¶é—´æ‰­æ›²](../è¯æ•ˆ/æ—¶é—´æ‰­æ›².md)** \- è¿™å¯ä»¥æè¿°ä¸ºæ„Ÿè§‰æ—¶é—´åœ¨åŠ é€Ÿï¼Œæ¯”å¹³æ—¶æ¸…é†’æ—¶è¿‡å¾—å¿«å¾—å¤šã€‚
    + **[æ€ç»´åŠ é€Ÿ](../è¯æ•ˆ/æ€ç»´åŠ é€Ÿ.md)**
    + **[æ€ç»´ç»„ç»‡](../è¯æ•ˆ/æ€ç»´ç»„ç»‡.md)** \- ä¸»è¦åœ¨è½»å¾®åˆ°ä¸­ç­‰å‰‚é‡ä¸‹è§‚å¯Ÿåˆ°ã€‚
    + **[æ€ç»´æ··ä¹±](../è¯æ•ˆ/æ€ç»´æ··ä¹±.md)** \- è¿™ç§æ•ˆåº”åœ¨è¾ƒé«˜å‰‚é‡ä¸‹è¡¨ç°å‡ºæ¥å¹¶åŠ å‰§ã€‚
    + **[æ¸…é†’](../è¯æ•ˆ/æ¸…é†’.md)** \- é«˜å‰‚é‡ä¸‹æŠ¥å‘Šæœ‰å¼ºçƒˆçš„æ¸…é†’æ„Ÿï¼Œå¹¶ä¸”åœ¨é•¿æ—¶é—´ä½¿ç”¨åå¯æŒç»­æ•°å°æ—¶ã€‚

### ä½“éªŒæŠ¥å‘Š

ç›®å‰æˆ‘ä»¬çš„ [ä½“éªŒç´¢å¼•](../æ–‡æ¡£/ä½“éªŒæŠ¥å‘Š.md) ä¸­è¿˜æ²¡æœ‰æè¿°è¯¥åŒ–åˆç‰©æ•ˆæœçš„è½¶äº‹æŠ¥å‘Šã€‚å…¶ä»–çš„ä½“éªŒæŠ¥å‘Šå¯ä»¥åœ¨è¿™é‡Œæ‰¾åˆ°å–µï¼š

* [Erowid Experience Vaults: MDPV](https://erowid.org/experiences/subs/exp_MDPV.shtml)

æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›
---------------------------

- ![Ambulance2.png](../æ–‡ä»¶/Ambulance2.png) **æœ¬æ¯’æ€§å’Œä¼¤å®³æ½œåŠ›éƒ¨åˆ†åªæ˜¯ä¸€ä¸ª[å­˜æ ¹ã€‚](../å…³äºæœ¬ç«™/ç¼–è¾‘æŒ‡å—.md)**å› æ­¤ï¼Œå®ƒå¯èƒ½åŒ…å«ä¸å®Œæ•´ç”šè‡³ **å±é™©é”™è¯¯** çš„ä¿¡æ¯ï¼ä½ å¯ä»¥é€šè¿‡ [æ‰©å……æˆ–æ›´æ­£å®ƒ](../å…³äºæœ¬ç«™/å‚ä¸è´¡çŒ®.md) æ¥æä¾›å¸®åŠ©ã€‚
*æ³¨æ„ï¼šå¦‚æœä½¿ç”¨è¿™ç§ç‰©è´¨ï¼Œè¯·åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶å¹¶ä½¿ç”¨ **[ä¼¤å®³å‡å°‘æªæ–½](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)**ã€‚*

MDPV åœ¨äººç±»ä½¿ç”¨æ–¹é¢çš„å†å²ç›¸å¯¹è¾ƒçŸ­ï¼Œåœ¨ 2004 å¹´ä¹‹å‰å¾ˆå°‘æœ‰äººæåŠä½¿ç”¨å®ƒã€‚å°½ç®¡æ›¾ç»è¢«è®¤ä¸ºæ˜¯ç°æœ‰å…´å¥‹å‰‚çš„æ½œåœ¨æ›¿ä»£å“ï¼Œä¸”æ¯’æ€§é£é™©è¾ƒä½ï¼Œä½†å‡ åå¹´æ¥å¹¶æœªåœ¨ä¸´åºŠç¯å¢ƒä¸­å¯¹äººç±» MDPV ç»™è¯è¿›è¡Œè¿‡å¹¿æ³›ç ”ç©¶ã€‚å°½ç®¡å¦‚æ­¤ï¼Œæœ€è¿‘å‡ é¡¹å…³äºé•¿æœŸä½¿ç”¨ MDPV å¯¼è‡´æŒç»­æ€§ç²¾ç¥ç—…çš„æ¡ˆä¾‹ç ”ç©¶æ˜¾ç¤ºï¼Œæ¥å—æŸäº› [æŠ—ç²¾ç¥ç—…è¯](../æ–‡æ¡£/æŠ—ç²¾ç¥ç—…è¯.md) å’Œä¸€çº¿ [æŠ—ç»„èƒºè¯](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ—ç»„èƒºè¯.md) æ²»ç–—çš„ä¸ªä½“æ¢å¤ç‡å¾ˆé«˜ã€‚[\[13\]](#cite_note-13) ç›®å‰å°šæ— å…³äº MDPV å¯¹äººè„‘ç¥ç»æ¯’æ€§çš„ç¡®åˆ‡æ•°æ®ã€‚

ç¤¾åŒºä¸­å°è¯•è¿‡ MDPV çš„äººçš„è½¶äº‹è¯æ®è¡¨æ˜ï¼Œå¦‚æœåªæ˜¯å•ç‹¬ä½å‰‚é‡æœç”¨å¹¶ä¸”å¶å°”ä½¿ç”¨ï¼Œè¯¥ç‰©è´¨æ²¡æœ‰ç›¸å…³çš„è´Ÿé¢å¥åº·å½±å“ï¼ˆä½†ä¸èƒ½å®Œå…¨ä¿è¯å“¦ï¼‰ã€‚

ä½“å¤–å’Œä½“å†…ç ”ç©¶çš„æ•°æ®è¡¨æ˜ï¼ŒMDPV å…·æœ‰ä¸ [ç”²åŸºè‹¯ä¸™èƒº](../è¯ç‰©/ç”²åŸºè‹¯ä¸™èƒº.md) å’Œ [å¯å¡å› ](../è¯ç‰©/å¯å¡å› .md) ç›¸ä¼¼çš„ç‰¹æ€§ï¼›äº‹å®ä¸Šï¼ŒMDPV åœ¨è®¸å¤šæ–¹é¢æ¯”è¿™ä¸¤ç§å…´å¥‹å‰‚æ›´æœ‰æ•ˆåŠ›ã€‚[\[14\]](#cite_note-14) MDPV ä½¿ç”¨å¼•èµ·çš„å¤šå·´èƒºå’Œå»ç”²è‚¾ä¸Šè…ºç´ çš„è¿‡åº¦å…´å¥‹ï¼ŒåŠ ä¸Š MDPV å¯èƒ½æ— æ³•äº§ç”Ÿè¡¥å¿æ€§çš„è¡€æ¸…ç´ èƒ½æ´»åŠ¨ï¼Œä¸ºå¯¹è¯¥è¯ç‰©äº§ç”Ÿè®¸å¤šæ•Œå¯¹å’Œç²¾ç¥ç—…ååº”åŸ‹ä¸‹äº†ä¼ç¬”ã€‚åœ¨åº”æ€¥å“åº”æƒ…å†µä¸­å·²ç»ç›®ç¹äº†è¿™äº›æ•Œå¯¹å€¾å‘ï¼Œå¹¶ä¸”è¿‡å»åœ¨ä¸€åå— MDPV å½±å“çš„ä¸ªäººæ¶æ„æ”»å‡»ä¸€åæ— è¾œè·¯äººåï¼Œä¹Ÿåœ¨ç”µè§†ä¸Šå¾—åˆ°äº†å¹¿æ³›æŠ¥é“ã€‚ç›®å‰å°šä¸ç¡®å®šè¯¥äººæ˜¯å¦æœ‰ä»»ä½•é¢„å…ˆå­˜åœ¨çš„ç²¾ç¥éšœç¢ï¼Œæˆ–è€…ä»–æ˜¯å¦å—åˆ°ä»»ä½•å…¶ä»–è¯ç‰©çš„å½±å“ã€‚\[*[æ¥æºè¯·æ±‚](../å…³äºæœ¬ç«™/æ¥æºè¯·æ±‚.md)*\]

### è‡´æ­»å‰‚é‡

MDPV çš„ç¡®åˆ‡è‡´æ­»å‰‚é‡å°šä¸æ¸…æ¥šï¼Œä¹Ÿæ²¡æœ‰åœ¨äººç±»ä¸­è¿›è¡Œè¿‡æ­£å¼ç ”ç©¶ã€‚ä½œä¸ºå‚è€ƒï¼Œä¸€ä»½æŠ¥å‘Šæ ¹æ®å°¸æ£€ç»“æœå°†ä¸€å 39 å²ç”·æ€§çš„è‡´æ­»å‰‚é‡å®šä¸º 0.4 å¾®å…‹æ¯æ¯«å‡æˆ–æ›´é«˜ï¼Œ[\[15\]](#cite_note-15) ä½†è¿™ä¸ªæ•°æ®å¤ªè¿‡ç‹¬ç‰¹ï¼Œå˜é‡å¤ªå¤šæ ·åŒ–ï¼Œæ— æ³•ä»ä¸­å¾—å‡ºä»»ä½•æœ‰æ„ä¹‰çš„ä¿¡æ¯ã€‚å¯ä»¥é€šè¿‡æ°”ç›¸è‰²è°±-è´¨è°±æ³•æˆ–æ¶²ç›¸è‰²è°±-è´¨è°±æ³•å®šé‡è¡€æ¶²ã€è¡€æµ†æˆ–å°¿æ¶²ä¸­çš„ MDPVï¼Œä»¥ç¡®è®¤ä½é™¢æ‚£è€…çš„ä¸­æ¯’è¯Šæ–­æˆ–ä¸ºæ³•åŒ»æ­»äº¡è°ƒæŸ¥æä¾›è¯æ®ã€‚åœ¨å¨±ä¹æ€§ä½¿ç”¨è¯¥è¯ç‰©çš„äººç¾¤ä¸­ï¼Œè¡€æ¶²æˆ–è¡€æµ† MDPV æµ“åº¦é¢„è®¡åœ¨ 10â€“50 Î¼g/L èŒƒå›´å†…ï¼Œåœ¨ä¸­æ¯’æ‚£è€…ä¸­ >50 Î¼g/Lï¼Œåœ¨æ€¥æ€§è¿‡é‡å—å®³è€…ä¸­ >300 Î¼g/Lã€‚[\[16\]](#cite_note-16)

å¼ºçƒˆå»ºè®®åœ¨ä½¿ç”¨è¿™ç§è¯ç‰©æ—¶é‡‡å– [ä¼¤å®³å‡å°‘æªæ–½](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md) å–µã€‚

### ä¾èµ–æ€§å’Œæ»¥ç”¨æ½œåŠ›

æ¯”å…¶ä»–å…´å¥‹å‰‚æ›´ç”šçš„æ˜¯ï¼Œé•¿æœŸä½¿ç”¨ MDPV å¯ä»¥è¢«è®¤ä¸ºå…·æœ‰é«˜åº¦æˆç˜¾æ€§ï¼Œå¹¶ä¸”å…·æœ‰å¾ˆé«˜çš„æ»¥ç”¨æ½œåŠ›ï¼Œèƒ½å¤Ÿå¯¼è‡´æŸäº›ç”¨æˆ·äº§ç”Ÿå¿ƒç†ä¾èµ–ã€‚å½“æˆç˜¾å‘å±•æ—¶ï¼Œå¦‚æœä¸€ä¸ªäººçªç„¶åœæ­¢ä½¿ç”¨ï¼Œå¯èƒ½ä¼šå‡ºç°æ¸´æœ›å’Œæˆ’æ–­ååº”ã€‚æˆç˜¾æ˜¯ MDPV ç”¨æˆ·é¢ä¸´çš„ä¸¥é‡é£é™©ï¼Œå› ä¸ºå®ƒå¾ˆå®¹æ˜“å¯¼è‡´å¼ºè¿«æ€§é‡å¤ç”¨è¯ï¼Œå¹¶å¯¼è‡´éå¸¸ä»¤äººä¸å¿«çš„ä¸‹å¤´ç—‡çŠ¶ã€‚

### ç²¾ç¥ç—…

ä¸»æ¡ç›®ï¼š[å…´å¥‹å‰‚ç²¾ç¥ç—…](../æ–‡æ¡£/å…´å¥‹å‰‚ç²¾ç¥ç—….md)

ç”¨æˆ·æŠ¥å‘Šè¡¨æ˜ï¼Œä¸ç»å¤§å¤šæ•°å…´å¥‹å‰‚ç›¸æ¯”ï¼Œé•¿æœŸæ»¥ç”¨æˆ–å•æ¬¡è¿‡é‡æœç”¨ MDPV å¯èƒ½æ›´å®¹æ˜“å¯¼è‡´ [ç²¾ç¥ç—…](../è¯æ•ˆ/ç²¾ç¥ç—….md)ã€‚MDPV çš„ç²¾ç¥ç—…ç—‡çŠ¶å¯èƒ½åŒ…æ‹¬ [å¹»å¬](../è¯æ•ˆ/å¹»å¬.md)ã€[è§†å¹»è§‰](../è¯æ•ˆ/å¹»è§‰.md)ã€ä¼¤å®³è‡ªå·±çš„å†²åŠ¨ã€ä¸¥é‡çš„ [ç„¦è™‘](../è¯æ•ˆ/ç„¦è™‘.md)ã€[ç‹‚èº](../è¯æ•ˆ/ç‹‚èº.md)ã€è‡ªå¤§ã€[åæ‰§å¦„æƒ³](../è¯æ•ˆ/å¦„æƒ³.md)ã€[å›°æƒ‘](../è¯æ•ˆ/å›°æƒ‘.md)ã€æ”»å‡»æ€§å¢åŠ å’Œ [æ˜“æ€’](../è¯æ•ˆ/æ˜“æ€’.md)ã€‚

### å±é™©çš„ç›¸äº’ä½œç”¨

***è­¦å‘Šï¼š*** *è®¸å¤šç²¾ç¥æ´»æ€§ç‰©è´¨å•ç‹¬ä½¿ç”¨æ—¶è¿˜ç®—å®‰å…¨ï¼Œä½†å½“ä¸æŸäº›å…¶ä»–ç‰©è´¨ç»“åˆä½¿ç”¨æ—¶ï¼Œå¯èƒ½ä¼šçªç„¶å˜å¾—å±é™©ç”šè‡³å±åŠç”Ÿå‘½ã€‚ä»¥ä¸‹åˆ—è¡¨åˆ—å‡ºäº†ä¸€äº›å·²çŸ¥çš„å±é™©ç›¸äº’ä½œç”¨ï¼ˆä½†è¿™ä¸ä¿è¯åŒ…å«æ‰€æœ‰æƒ…å†µå“¦ï¼‰ã€‚*

*åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶ï¼ˆä¾‹å¦‚ [Google](https://www.google.com), [DuckDuckGo](https://www.duckduckgo.com), [PubMed](https://pubmed.ncbi.nlm.nih.gov/)ï¼‰ä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆæ˜¯å®‰å…¨çš„ã€‚ä¸€äº›åˆ—å‡ºçš„ç›¸äº’ä½œç”¨æ¥è‡ª [TripSit](https://combo.tripsit.me)ã€‚*

* **[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)** \- MDPV ä¸å…¶ä»– [å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md) ç»“åˆä½¿ç”¨å¯èƒ½æœ‰å±é™©ï¼Œå› ä¸ºå®ƒä¼šå°† [å¿ƒç‡](../è¯æ•ˆ/å¿ƒç‡å¢å¿«.md) å’Œ [è¡€å‹](../è¯æ•ˆ/è¡€å‹å‡é«˜.md) æé«˜åˆ°å±é™©æ°´å¹³ã€‚
* **[25x-NBOMe](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/2,5-äºŒç”²æ°§åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md) & [25x-NBOH](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/2,5-äºŒç”²æ°§åŸºè‹¯ä¹™èƒºç±»ç‰©è´¨.md)** \- 25x åŒ–åˆç‰©å…·æœ‰é«˜åº¦åˆºæ¿€æ€§ï¼Œå¯¹èº«ä½“é€ æˆè´Ÿæ‹…ã€‚åº”ä¸¥æ ¼é¿å…ä¸ MDPV ç»“åˆä½¿ç”¨ï¼Œå› ä¸ºå­˜åœ¨è¿‡åº¦ [åˆºæ¿€](../è¯æ•ˆ/åˆºæ¿€.md) å’Œå¿ƒè„è´Ÿæ‹…çš„é£é™©ã€‚è¿™å¯èƒ½å¯¼è‡´ [è¡€å‹å‡é«˜](../è¯æ•ˆ/è¡€å‹å‡é«˜.md)ã€[è¡€ç®¡æ”¶ç¼©](../è¯æ•ˆ/è¡€ç®¡æ”¶ç¼©.md)ã€æƒŠæå‘ä½œã€[æ€ç»´å¾ªç¯](../è¯æ•ˆ/æ€ç»´å¾ªç¯.md)ã€[ç™«ç—«å‘ä½œ](../è¯æ•ˆ/ç™«ç—«å‘ä½œ.md)ï¼Œåœ¨æç«¯æƒ…å†µä¸‹ä¼šå¯¼è‡´å¿ƒåŠ›è¡°ç«­ã€‚
* **[é…’ç²¾](../è¯ç‰©/é…’ç²¾.md)** \- å°†é…’ç²¾ä¸ [å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md) ç»“åˆä½¿ç”¨å¯èƒ½å¾ˆå±é™©ï¼Œå› ä¸ºå­˜åœ¨æ„å¤–è¿‡åº¦ä¸­æ¯’çš„é£é™©ã€‚å…´å¥‹å‰‚ä¼šæ©ç›–é…’ç²¾çš„ [æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md) ä½œç”¨ï¼Œè€Œå¤§å¤šæ•°äººæ˜¯ç”¨è¿™ç§ä½œç”¨æ¥è¯„ä¼°è‡ªå·±çš„é†‰é…’ç¨‹åº¦çš„ã€‚ä¸€æ—¦å…´å¥‹å‰‚è¯æ•ˆæ¶ˆé€€ï¼Œ[æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md) ä½œç”¨å°†ä¸å†å—é˜»ï¼Œè¿™å¯èƒ½å¯¼è‡´æ–­ç‰‡å’Œä¸¥é‡çš„ [å‘¼å¸æŠ‘åˆ¶](../è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)ã€‚å¦‚æœæ··åˆä½¿ç”¨ï¼Œç”¨æˆ·åº”ä¸¥æ ¼é™åˆ¶è‡ªå·±æ¯å°æ—¶åªå–ä¸€å®šé‡çš„é…’ç²¾ã€‚
* **[å³ç¾æ²™èŠ¬](../è¯ç‰©/å³ç¾æ²™èŠ¬.md)** \- åº”é¿å…ä¸ [å³ç¾æ²™èŠ¬](../è¯ç‰©/å³ç¾æ²™èŠ¬.md) ç»“åˆä½¿ç”¨ï¼Œå› ä¸ºå®ƒå¯¹ [è¡€æ¸…ç´ ](../æ–‡æ¡£/è¡€æ¸…ç´ .md) å’Œ [å»ç”²è‚¾ä¸Šè…ºç´ ](../æ–‡æ¡£/å»ç”²è‚¾ä¸Šè…ºç´ .md) å†æ‘„å–æœ‰æŠ‘åˆ¶ä½œç”¨ã€‚è¿™ä¼šå¢åŠ  [æƒŠæå‘ä½œ](../è¯æ•ˆ/æƒŠæå‘ä½œ.md) å’Œé«˜è¡€å‹å±è±¡çš„é£é™©ï¼Œæˆ–è€…å¦‚æœä¸è¡€æ¸…ç´ é‡Šæ”¾å‰‚ï¼ˆ[MDMA](../è¯ç‰©/MDMA.md)ã€[ç”²é…®](../è¯ç‰©/ç”²å¡è¥¿é…®.md)ã€[4-MMC](../è¯ç‰©/4-MMC.md) ç­‰ï¼‰ç»“åˆä½¿ç”¨ï¼Œä¼šæœ‰ [è¡€æ¸…ç´ ç»¼åˆå¾](../æ–‡æ¡£/è¡€æ¸…ç´ ç»¼åˆå¾.md) çš„é£é™©ã€‚ä»”ç»†ç›‘æµ‹è¡€å‹ï¼Œé¿å…å‰§çƒˆä½“åŠ›æ´»åŠ¨ã€‚
* **[MDMA](../è¯ç‰©/MDMA.md)** \- å½“å­˜åœ¨å…¶ä»– [å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md) æ—¶ï¼ŒMDMA çš„ä»»ä½•ç¥ç»æ¯’æ€§ä½œç”¨éƒ½å¯èƒ½å¢åŠ ã€‚è¿˜å­˜åœ¨è¡€å‹è¿‡é«˜å’Œå¿ƒè„è´Ÿæ‹…ï¼ˆå¿ƒè„æ¯’æ€§ï¼‰çš„é£é™©ã€‚
* **[MXE](../è¯ç‰©/MXE.md)** \- ä¸€äº›æŠ¥å‘Šè¡¨æ˜ï¼Œä¸ MXE ç»“åˆä½¿ç”¨å¯èƒ½ä¼šå±é™©åœ°å¢åŠ è¡€å‹ï¼Œå¹¶å¢åŠ  [ç‹‚èº](../è¯æ•ˆ/ç‹‚èº.md) å’Œ [ç²¾ç¥ç—…](../è¯æ•ˆ/ç²¾ç¥ç—….md) çš„é£é™©ã€‚
* **[è§£ç¦»å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/è§£ç¦»å‰‚.md)** \- è¿™ä¸¤ç±»ç‰©è´¨éƒ½æœ‰å¯¼è‡´ [å¦„æƒ³](../è¯æ•ˆ/å¦„æƒ³.md)ã€[ç‹‚èº](../è¯æ•ˆ/ç‹‚èº.md) å’Œ [ç²¾ç¥ç—…](../è¯æ•ˆ/ç²¾ç¥ç—….md) çš„é£é™©ï¼Œç»“åˆä½¿ç”¨æ—¶è¿™äº›é£é™©å¯èƒ½ä¼šæˆå€å¢åŠ ã€‚
* **[å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)** \- MDPV ä¸å…¶ä»– [å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)ï¼ˆå¦‚ [å¯å¡å› ](../è¯ç‰©/å¯å¡å› .md)ï¼‰ç»“åˆä½¿ç”¨å¯èƒ½æœ‰å±é™©ï¼Œå› ä¸ºå®ƒä»¬ä¼šå°† [å¿ƒç‡](../è¯æ•ˆ/å¿ƒç‡å¢å¿«.md) å’Œ [è¡€å‹](../è¯æ•ˆ/è¡€å‹å‡é«˜.md) æé«˜åˆ°å±é™©æ°´å¹³ã€‚
* **[æ›²é©¬å¤š](../è¯ç‰©/æ›²é©¬å¤š.md)** \- ä¼—æ‰€å‘¨çŸ¥ï¼Œæ›²é©¬å¤šä¼šé™ä½ç™«ç—«å‘ä½œé˜ˆå€¼ [\[17\]](#cite_note-17)ï¼Œä¸å…´å¥‹å‰‚ç»“åˆä½¿ç”¨å¯èƒ½ä¼šè¿›ä¸€æ­¥å¢åŠ è¿™ç§é£é™©ã€‚
* **[MDMA](../è¯ç‰©/MDMA.md)** \- å½“ä¸ [è‹¯ä¸™èƒº](../è¯ç‰©/è‹¯ä¸™èƒº.md) å’Œå…¶ä»–å…´å¥‹å‰‚ç»“åˆä½¿ç”¨æ—¶ï¼ŒMDMA çš„ç¥ç»æ¯’æ€§ä½œç”¨å¯èƒ½ä¼šå¢åŠ ã€‚
* **[å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚](../æ–‡æ¡£/å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚.md)** \- è¿™ç§ç»„åˆå¯èƒ½ä¼šå°†å¤šå·´èƒºç­‰ç¥ç»é€’è´¨çš„é‡å¢åŠ åˆ°å±é™©ç”šè‡³è‡´å‘½çš„æ°´å¹³ã€‚ä¾‹å­åŒ…æ‹¬ [éª†é©¼è“¬](../è¯ç‰©/éª†é©¼è“¬.md)ã€[*Banisteriopsis caapi*](../è¯ç‰©/æ­»è—¤æ°´.md) å’Œä¸€äº› [æŠ—æŠ‘éƒè¯](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ—æŠ‘éƒè¯.md)ã€‚[\[18\]](#cite_note-18)
* **[å¯å¡å› ](../è¯ç‰©/å¯å¡å› .md)** \- è¿™ç§ç»„åˆå¯èƒ½ä¼šå¢åŠ å¿ƒè„è´Ÿæ‹…ã€‚

æ³•å¾‹åœ°ä½
------------

2014 å¹´ 9 æœˆï¼Œæ¬§æ´²ç†äº‹ä¼šå†³å®šï¼Œæˆå‘˜å›½åº”åœ¨ 2015 å¹´ 10 æœˆ 2 æ—¥ä¹‹å‰å¯¹ MDPV å®æ–½æ§åˆ¶æªæ–½å’Œåˆ‘äº‹å¤„ç½šã€‚[\[19\]](#cite_note-19)

* **æ¾³å¤§åˆ©äºš**: åœ¨è¥¿æ¾³å¤§åˆ©äºšå·ï¼ŒMDPV æ ¹æ® 1964 å¹´æ¯’è¯æ³•æ¡ˆå·²è¢«ç¦æ­¢ï¼Œæˆªè‡³ 2012 å¹´ 2 æœˆ 11 æ—¥ï¼Œå®ƒå·²è¢«åˆ—å…¥ 1964 å¹´æ¯’è¯æ³•æ¡ˆé™„å½• A é™„è¡¨ 9 ä¸­ã€‚è¥¿æ¾³å¤§åˆ©äºšå·æ£€å¯Ÿé•¿å®£å¸ƒï¼Œä»»ä½•æ‰“ç®—å‡ºå”®æˆ–ä¾›åº” MDPV çš„äººéƒ½å°†é¢ä¸´æœ€é«˜ 100,000 ç¾å…ƒçš„ç½šæ¬¾æˆ– 25 å¹´ç›‘ç¦ã€‚ç”¨æˆ·é¢ä¸´ 2000 ç¾å…ƒçš„ç½šæ¬¾æˆ–ä¸¤å¹´ç›‘ç¦ã€‚å› æ­¤ï¼Œä»»ä½•è¢«å‘ç°æŒæœ‰ MDPV çš„äººéƒ½å¯èƒ½è¢«æŒ‡æ§æŒæœ‰ã€å‡ºå”®ã€ä¾›åº”æˆ–æ„å›¾å‡ºå”®æˆ–ä¾›åº”ã€‚[\[20\]](#cite_note-20)
* **å¥¥åœ°åˆ©**: è‡ª 2019 å¹´ 6 æœˆ 26 æ—¥èµ·ï¼Œæ ¹æ® SMG (Suchtmittelgesetz Ã–sterreich)ï¼ŒæŒæœ‰ã€ç”Ÿäº§å’Œé”€å”® MDPV å‡å±è¿æ³•ã€‚[\[21\]](#cite_note-21)
* **æ¯”åˆ©æ—¶**: æˆªè‡³ 2013 å¹´ 3 æœˆ 20 æ—¥ï¼ŒMDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **å·´è¥¿**: ç”Ÿäº§ã€é”€å”®æˆ–æŒæœ‰ MDPV å‡å±è¿æ³•ï¼Œå› ä¸ºå®ƒè¢«åˆ—å…¥ Portaria SVS/MS nÂº 344ã€‚[\[22\]](#cite_note-22)
* **ä¿åŠ åˆ©äºš**: æˆªè‡³ 2011 å¹´ 2 æœˆï¼ŒMDPV å—éº»é†‰ç‰©è´¨ç®¡åˆ¶æ³•ç®¡åˆ¶ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **åŠ æ‹¿å¤§**: 2012 å¹´ 6 æœˆ 5 æ—¥ï¼ŒåŠ æ‹¿å¤§å«ç”Ÿéƒ¨é•¿ Leona Aglukkaq å®£å¸ƒ MDPV å°†è¢«åˆ—å…¥ç®¡åˆ¶è¯ç‰©å’Œç‰©è´¨æ³•æ¡ˆé™„è¡¨ Iï¼Œè¯¥æ³•æ¡ˆäº 2012 å¹´ 9 æœˆ 26 æ—¥é€šè¿‡æˆä¸ºæ³•å¾‹ã€‚[\[23\]](#cite_note-23)
* **å…‹ç½—åœ°äºš**: MDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **å¡æµ¦è·¯æ–¯**: MDPV æ˜¯ B ç±»å—ç®¡åˆ¶ç‰©è´¨ï¼Œå› ä¸ºå®ƒåŒ…å«åœ¨å¡è¥¿é…®ç±»ç‰©è´¨å…œåº•æ¡æ¬¾ä¸­ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **æ·å…‹å…±å’Œå›½**: MDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **ä¸¹éº¦**: MDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **çˆ±æ²™å°¼äºš**: æˆªè‡³ 2010 å¹´ 11 æœˆ 29 æ—¥ï¼ŒMDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **èŠ¬å…°**: MDPV åœ¨èŠ¬å…°è¢«æ˜ç¡®åˆ—ä¸ºå—ç®¡åˆ¶ç‰©è´¨ï¼ˆæˆªè‡³ 2010 å¹´ 6 æœˆ 28 æ—¥è¢«åˆ—ä¸ºé™„å½• IV ç‰©è´¨ï¼‰ã€‚[\[24\]](#cite_note-24)
* **æ³•å›½**: æˆªè‡³ 2012 å¹´ 8 æœˆ 2 æ—¥ï¼ŒMDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **å¾·å›½**: æˆªè‡³ 2012 å¹´ 7 æœˆ 26 æ—¥ï¼ŒMDPV å— Anlage II BtMG (*éº»é†‰å“æ³•ï¼Œé™„è¡¨ II*) [\[25\]](#cite_note-25) ç®¡åˆ¶ã€‚[\[26\]](#cite_note-26) æœªç»è®¸å¯åˆ¶é€ ã€æŒæœ‰ã€è¿›å£ã€å‡ºå£ã€è´­ä¹°ã€é”€å”®ã€é‡‡è´­æˆ–åˆ†å‘å®ƒæ˜¯è¿æ³•çš„ã€‚[\[27\]](#cite_note-27)
* **åŒˆç‰™åˆ©**: MDPV æ˜¯é™„è¡¨ A å—ç®¡åˆ¶ç²¾ç¥è¯ç‰©ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **çˆ±å°”å…°**: è‡ª 2010 å¹´ 5 æœˆ 11 æ—¥èµ·ï¼ŒMDPV å—æ»¥ç”¨è¯ç‰©æ³•æ¡ˆæ¶µç›–ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **æ„å¤§åˆ©**: æˆªè‡³ 2011 å¹´ 12 æœˆ 29 æ—¥ï¼ŒMDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **æ‹‰è„±ç»´äºš**: MDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **å¢æ£®å ¡**: æˆªè‡³ 2012 å¹´ 7 æœˆ 30 æ—¥ï¼ŒMDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **æŒªå¨**: æˆªè‡³ 2013 å¹´ 2 æœˆ 14 æ—¥ï¼ŒMDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **æ³¢å…°**: MDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **æ–¯æ´›ä¼å…‹**: æˆªè‡³ 2011 å¹´ 3 æœˆ 1 æ—¥ï¼ŒMDPV æ˜¯é™„è¡¨ I å—ç®¡åˆ¶ç²¾ç¥è¯ç‰©ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **æ–¯æ´›æ–‡å°¼äºš**: MDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **ç‘å…¸**: MDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1) åœ¨ç‘å…¸ï¼Œä¸€å 33 å²çš„ç”·å­å› æŒæœ‰åœ¨åˆ‘äº‹å®šç½ªå‰è·å¾—çš„ 250 å…‹ MDPVï¼Œè¢«ä¸Šè¯‰æ³•é™¢ HovrÃ¤tt åˆ¤å¤„å…­å¹´ç›‘ç¦ã€‚[\[28\]](#cite_note-28)
* **ç‘å£«**: MDPV æ˜¯å—ç®¡åˆ¶çš„ç‰©è´¨ï¼Œåœ¨ Verzeichnis D ä¸­è¢«æ˜ç¡®å‘½åã€‚[\[29\]](#cite_note-29)
* **åœŸè€³å…¶**: MDPV æ˜¯å—ç®¡åˆ¶ç‰©è´¨ã€‚[\[1\]](#cite_note-EMCDDA-1)
* **è‹±å›½**: ç”±äºå¡è¥¿é…®ç±»ç‰©è´¨å…œåº•æ¡æ¬¾ï¼ŒMDPV åœ¨è‹±å›½æ˜¯ B ç±»è¯ç‰©ã€‚[\[30\]](#cite_note-30)
* **ç¾å›½**: 2011 å¹´ 10 æœˆ 21 æ—¥ï¼ŒMDPV æˆä¸º DEA è”é‚¦é™„è¡¨è¯ç‰©ã€‚DEA å‘å¸ƒäº†ä¸ºæœŸä¸€å¹´çš„ MDPV ä¸´æ—¶ç¦ä»¤ï¼Œå°†å…¶å½’ç±»ä¸ºé™„è¡¨ I ç‰©è´¨ã€‚2011 å¹´ 12 æœˆ 8 æ—¥ï¼Œæ ¹æ®åˆæˆè¯ç‰©ç®¡åˆ¶æ³•æ¡ˆï¼Œç¾å›½ä¼—è®®é™¢æŠ•ç¥¨ç¦æ­¢ MDPV å’Œå„ç§å…¶ä»–ä»¥å‰åœ¨å•†åº—åˆæ³•é”€å”®çš„åˆæˆè¯ç‰©ã€‚[\[31\]](#cite_note-31)

å¦è§
--------

* [è´Ÿè´£ä»»çš„ç”¨è¯](../æ–‡æ¡£/è´Ÿè´£ä»»çš„ç”¨è¯ç´¢å¼•é¡µ.md)
* [ç ”ç©¶ç”¨åŒ–å­¦å“](../æ–‡æ¡£/ç ”ç©¶ç”¨åŒ–å­¦å“.md)
* [å…´å¥‹å‰‚](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)
* [å¡è¥¿é…®ç±»ç‰©è´¨](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¡è¥¿é…®ç±»ç‰©è´¨.md)
* [å¡å’¯æˆŠé…®](../æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å¡å’¯æˆŠé…®ç±»ç‰©è´¨.md)
* [Î±-PVP](../è¯ç‰©/Î±-PVP.md)
* [æ™®ç½—æ—å¦ (Prolintane)](../è¯ç‰©/Prolintane.md)

å¤–éƒ¨é“¾æ¥
--------------

* [MDPV (Wikipedia)](https://en.wikipedia.org/wiki/Methylenedioxypyrovalerone)
* [MDPV (Erowid Vault)](https://erowid.org/chemicals/mdpv/mdpv.shtml)
* [MDPV (Isomer Design)](https://isomerdesign.com/PiHKAL/explore.php?id=2143)
* [MDPV (Drugs\-Forum)](https://drugs-forum.com/wiki/MDPV)

### è®¨è®º

* [MDPV Megathread (Bluelight)](http://www.bluelight.org/vb/threads/278421-MDPV-Megathread)

å‚è€ƒæ–‡çŒ®
----------

1. â†‘ [1\.00](#cite_ref-EMCDDA_1-0) [1\.01](#cite_ref-EMCDDA_1-1) [1\.02](#cite_ref-EMCDDA_1-2) [1\.03](#cite_ref-EMCDDA_1-3) [1\.04](#cite_ref-EMCDDA_1-4) [1\.05](#cite_ref-EMCDDA_1-5) [1\.06](#cite_ref-EMCDDA_1-6) [1\.07](#cite_ref-EMCDDA_1-7) [1\.08](#cite_ref-EMCDDA_1-8) [1\.09](#cite_ref-EMCDDA_1-9) [1\.10](#cite_ref-EMCDDA_1-10) [1\.11](#cite_ref-EMCDDA_1-11) [1\.12](#cite_ref-EMCDDA_1-12) [1\.13](#cite_ref-EMCDDA_1-13) [1\.14](#cite_ref-EMCDDA_1-14) [1\.15](#cite_ref-EMCDDA_1-15) [1\.16](#cite_ref-EMCDDA_1-16) [1\.17](#cite_ref-EMCDDA_1-17) [1\.18](#cite_ref-EMCDDA_1-18) [1\.19](#cite_ref-EMCDDA_1-19) [1\.20](#cite_ref-EMCDDA_1-20) ["MDPV: EMCDDAâ€“Europol Joint Report on a new psychoactive substance: MDPV (3,4\-methylenedioxypyrovalerone)"](http://www.emcdda.europa.eu/system/files/publications/819/TDAS14001ENN_466653.pdf) (PDF). European Monitoring Centre for Drugs and Drug Addiction. Retrieved December 27, 2019.Â 
2. [â†‘](#cite_ref-2) ["Monkey dust "epidemic" causing drug users to experience violent hallucinations"](https://www.newsweek.com/what-monkey-dust-bath-salt-mpvd-drug-causing-epidemic-violent-hallucinations-1068295). *Newsweek* (in English). 10 August 2018. Retrieved 17 August 2018.Â 
3. â†‘ [3\.0](#cite_ref-KoppePatent_3-0) [3\.1](#cite_ref-KoppePatent_3-1) Koppe, H., Ludwig, G., Zeile, K., [*1\-(3â€™,4â€™\-methylenedioxy\-phenyl)\-2\-pyrrolidino\-alkanones\-(1\)*](https://patents.google.com/patent/US3478050/en)Â 
4. [â†‘](#cite_ref-4) MDPV Summary \| <http://www.who.int/medicines/areas/quality_safety/4_13_Review.pdf?ua=1>
5. [â†‘](#cite_ref-5) [*MDPV \- TripSit wiki*](https://wiki.tripsit.me/wiki/MDPV)Â 
6. [â†‘](#cite_ref-6) <https://www.deadiversion.usdoj.gov/drug_chem_info/mdpv.pdf>
7. [â†‘](#cite_ref-7) <http://www.who.int/medicines/areas/quality_safety/4_13_Review.pdf?ua=1>
8. [â†‘](#cite_ref-8) [*MDPV \- Erowid Exp \- â€œPersonal Research Comedown Guideâ€*](https://erowid.org/experiences/exp.php?ID=98601)Â 
9. [â†‘](#cite_ref-9) [*MDPV \- Erowid Exp \- â€œSeemingly Real Paranoid Hallucination Hellâ€*](https://erowid.org/experiences/exp.php?ID=91741)Â 
10. [â†‘](#cite_ref-10) [*MDPV \- Erowid Exp \- â€œPsychosisâ€*](https://www.erowid.org/experiences/exp.php?ID=78382)Â 
11. [â†‘](#cite_ref-11) Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, et al. (March 2014\). ["Potent rewarding and reinforcing effects of the synthetic cathinone 3,4\-methylenedioxypyrovalerone (MDPV)"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3473160). *Addiction Biology*. **19** (2\): 165â€“74\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1111/j.1369\-1600\.2012\.00474\.x](//doi.org/10.1111%2Fj.1369-1600.2012.00474.x). [PMC](http://en.wikipedia.org/wiki/PubMed_Central "wikipedia:PubMed Central")Â [3473160](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3473160)â€¯![Freely accessible](https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/langen-gb-20px-Lock-green.svg.png "Freely accessible"). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier")Â [22784198](//www.ncbi.nlm.nih.gov/pubmed/22784198).Â 
12. [â†‘](#cite_ref-12) Coppola M, Mondola R (January 2012\). "3,4\-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online". *Toxicology Letters*. **208** (1\): 12â€“5\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/j.toxlet.2011\.10\.002](//doi.org/10.1016%2Fj.toxlet.2011.10.002). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier")Â [22008731](//www.ncbi.nlm.nih.gov/pubmed/22008731).Â 
13. [â†‘](#cite_ref-13) Studies concerning MDPV hospitalization, pages 19 to 25\. \| <http://www.who.int/medicines/areas/quality_safety/4_13_Review.pdf?ua=1>
14. [â†‘](#cite_ref-14) MDPV In\-vivo statistics \| <http://www.who.int/medicines/areas/quality_safety/4_13_Review.pdf?ua=1>
15. [â†‘](#cite_ref-15) Wyman, J. F., Lavins, E. S., Engelhart, D., Armstrong, E. J., Snell, K. D., Boggs, P. D., Taylor, S. M., Norris, R. N., Miller, F. P. (1 April 2013\). ["Postmortem Tissue Distribution of MDPV Following Lethal Intoxication by "Bath Salts""](https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bkt001). *Journal of Analytical Toxicology*. **37** (3\): 182â€“185\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1093/jat/bkt001](//doi.org/10.1093%2Fjat%2Fbkt001). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0146\-4760](//www.worldcat.org/issn/0146-4760).Â 
16. [â†‘](#cite_ref-16) Baselt, R. C. (2014\). *Disposition of toxic drugs and chemicals in man* (Tenth edition ed.). Biomedical Publications. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9780962652394](http://en.wikipedia.org/wiki/Special:BookSources/9780962652394 "wikipedia:Special:BookSources/9780962652394").Â CS1 maint: Extra text ([link](/w/index.php?title=Category:CS1_maint:_Extra_text&action=edit&redlink=1 "Category:CS1 maint: Extra text (page does not exist)"))
17. [â†‘](#cite_ref-17) Talaie, H.; Panahandeh, R.; Fayaznouri, M. R.; Asadi, Z.; Abdollahi, M. (2009\). "Dose\-independent occurrence of seizure with tramadol". *Journal of Medical Toxicology*. **5** (2\): 63â€“67\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1007/BF03161089](//doi.org/10.1007%2FBF03161089). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN "wikipedia:International Standard Serial Number")Â [1937\-6995](//www.worldcat.org/issn/1937-6995). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1556\-9039](//www.worldcat.org/issn/1556-9039). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC")Â [163567183](//www.worldcat.org/oclc/163567183).Â 
18. [â†‘](#cite_ref-18) Gillman, P. K. (2005\). ["Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity"](https://bjanaesthesia.org/article/S0007-0912(17)34956-5/fulltext). *British Journal of Anaesthesia*. **95** (4\): 434â€“441\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1093/bja/aei210](//doi.org/10.1093%2Fbja%2Faei210)â€¯![Freely accessible](https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/langen-gb-20px-Lock-green.svg.png "Freely accessible"). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN "wikipedia:International Standard Serial Number")Â [1471\-6771](//www.worldcat.org/issn/1471-6771). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0007\-0912](//www.worldcat.org/issn/0007-0912). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC")Â [01537271](//www.worldcat.org/oclc/01537271). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier")Â [16051647](//www.ncbi.nlm.nih.gov/pubmed/16051647).Â 
19. [â†‘](#cite_ref-19) ["Council Implementing Decision on subjecting 25I\-NBOMe, AH\-7921, MDPV and methoxetamine to control measures"](https://op.europa.eu/o/opportal-service/download-handler?identifier=025bb164-4937-11e4-a0cb-01aa75ed71a1&format=pdfa1a&language=en&productionSystem=cellar&part=). *Official Journal of the European Union*. Office for Official Publications of the European Communites (published October 1, 2014\). September 25, 2014\. pp. 22â€“26\. [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC")Â [52224955](//www.worldcat.org/oclc/52224955). L 287\.Â 
20.